These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19481805)

  • 41. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y; Yang XW; Song Y; Yu F; Zhao MH
    Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
    Gargiulo Mde L; Gómez G; Khoury M; Collado MV; Suárez L; Álvarez C; Sarano J
    Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-C1q autoantibodies do not correlate with the occurrence or severity of experimental lupus nephritis.
    Bigler C; Hopfer H; Danner D; Schaller M; Mihatsch MJ; Trendelenburg M
    Nephrol Dial Transplant; 2011 Apr; 26(4):1220-8. PubMed ID: 20841491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-C1q, anti-chromatin/nucleosome, and anti-dsDNA antibodies in juvenile systemic lupus erythematosus patients.
    Jesus AA; Campos LM; Liphaus BL; Carneiro-Sampaio M; Mangueira CL; Rosseto EA; Silva CA; Scheinberg M
    Rev Bras Reumatol; 2012 Dec; 52(6):976-81. PubMed ID: 23223707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-C1q antibodies in juvenile-onset systemic lupus erythematosus.
    Jesus AA; Silva CA; Carneiro-Sampaio M; Sheinberg M; Mangueira CL; Marie SK; Liphaus BL
    Ann N Y Acad Sci; 2009 Sep; 1173():235-8. PubMed ID: 19758156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis.
    Tan Y; Song D; Wu LH; Yu F; Zhao MH
    BMC Nephrol; 2013 Mar; 14():63. PubMed ID: 23510032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of anti-nuclesome and anti C1q antibodies with lupus nephritis in an Egyptian cohort of patients with systemic lupus erythematosus.
    Metwally IM; Eesa NN; Yacoub MH; Elsman RM
    Adv Rheumatol; 2019 Mar; 59(1):10. PubMed ID: 30832710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A; Cheung BM; Mok CC; Leung R; Lau CS
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis.
    do Nascimento AP; Viana Vdos S; Testagrossa Lde A; Leon EP; Borba EF; Barros RT; Bonfá E
    Arthritis Rheum; 2006 May; 54(5):1568-72. PubMed ID: 16645990
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biochemical analysis of the epitope specificities of anti-C1q autoantibodies accompanying human lupus nephritis reveals them as a dynamic population in the course of the disease.
    Stoyanova V; Tchorbadjieva M; Deliyska B; Vasilev V; Tsacheva I
    Immunol Lett; 2012; 148(1):69-76. PubMed ID: 22981967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis.
    Yin Y; Wu X; Shan G; Zhang X
    Lupus; 2012 Sep; 21(10):1088-97. PubMed ID: 22777943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-C1q antibody as a marker of disease activity in systemic lupus erythematosus.
    Kumar A; Gupta R; Varghese T; Pande RM; Singal VK; Garg OP
    Indian J Med Res; 1999 Dec; 110():190-3. PubMed ID: 10701298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Existence of different but overlapping IgG- and IgM-binding sites on the globular domain of human C1q.
    Zlatarova AS; Rouseva M; Roumenina LT; Gadjeva M; Kolev M; Dobrev I; Olova N; Ghai R; Jensenius JC; Reid KB; Kishore U; Kojouharova MS
    Biochemistry; 2006 Aug; 45(33):9979-88. PubMed ID: 16906756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical value of autoantibodies against C1q in children with glomerulonephritis.
    Kozyro I; Perahud I; Sadallah S; Sukalo A; Titov L; Schifferli J; Trendelenburg M
    Pediatrics; 2006 May; 117(5):1663-8. PubMed ID: 16651321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of antiphospholipid antibodies in lupus nephritis.
    Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis.
    Soliman AF; Egailla SE; Abdel-Gawad ER; Mansour AI; ElKhouly TH; Mahgoub MY
    Egypt J Immunol; 2016 Jan; 23(1):107-116. PubMed ID: 28502158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
    Heshmat NM; El-Kerdany TH
    Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus.
    Moura CG; Mangueira CL; Cruz LA; Cruz CM
    Nephron Clin Pract; 2011; 118(4):c355-60. PubMed ID: 21325866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.